Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06985238 · ClinicalTrials.gov registry record · NA

Stratagen Quantitative Prostate MRI Platform Pilot Study

A NA study of Prostate Cancer, sponsored by Stratagen Bio.

Recruiting
Registry status
NA
Development phase
75
Enrollment target
2
Study locations

NCT06985238: Recruiting NA study of Prostate Cancer, sponsored by Stratagen Bio.

NCT06985238 is a NA study of Prostate Cancer that is actively recruiting participants, run by Stratagen Bio. The registered enrollment target is 75 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06985238, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by Stratagen Bio.

RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target
2
Study locations

Study Summary

The goal of this clinical trial is to assess the safety and feasibility of the Stratagen Quantitative Prostate MRI Platform when used in addition to the standard scans conducted during the existing prostate MRI sessions. * What severe problems, if any, occur because of the use of the Stratagen Quantitative Prostate MRI Platform? * Can the data collected be used to measure quantitative MRI parameters? Participants will: \- Receive up to 15 minutes of additional MRI scan time during the existing prostate MRI imaging session.

Conditions Studied

Prostate Cancer

Interventions

  • DEVICE MRI

Study Locations (2)

New York

  • Urology Clinic at Sawgrass - Rochester

Virginia

  • Virginia Urology - Richmond

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2025-09-24
Est. Completion 2026-10-31
Phase NA

Sponsor

Stratagen Bio

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06985238

The ClinicalTrials.gov registry entry for NCT06985238 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (88% lower). The listed sponsor is Stratagen Bio, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which MRI is the first listed.

NCT06985238 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Virginia.

Frequently Asked Questions

What is clinical trial NCT06985238 about?

NCT06985238 is a clinical study titled "Stratagen Quantitative Prostate MRI Platform Pilot Study". The goal of this clinical trial is to assess the safety and feasibility of the Stratagen Quantitative Prostate MRI Platform when used in addition to the standard scans conducted during the existing prostate MRI sessions. * What severe problems, if any, occur because of the use of the Stratagen Quan...

What is the current status of trial NCT06985238?

This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2025-09-24. Estimated completion is 2026-10-31.

What conditions does trial NCT06985238 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT06985238?

The interventions under investigation include: MRI (DEVICE).

Who is sponsoring clinical trial NCT06985238?

This trial is sponsored by Stratagen Bio, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06985238 being conducted?

This trial has 2 study locations across New York, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.